Ionis Pharmaceuticals (IONS) Receivables - Other (2016 - 2025)
Ionis Pharmaceuticals (IONS) has 17 years of Receivables - Other data on record, last reported at $24.6 million in Q3 2025.
- For Q3 2025, Receivables - Other rose 37.26% year-over-year to $24.6 million; the TTM value through Sep 2025 reached $24.6 million, up 37.26%, while the annual FY2024 figure was $92.2 million, 5.72% down from the prior year.
- Receivables - Other reached $24.6 million in Q3 2025 per IONS's latest filing, down from $52.6 million in the prior quarter.
- Across five years, Receivables - Other topped out at $142.4 million in Q3 2023 and bottomed at $5.1 million in Q1 2024.
- Average Receivables - Other over 5 years is $38.1 million, with a median of $25.5 million recorded in 2022.
- Peak YoY movement for Receivables - Other: soared 2042.35% in 2023, then crashed 87.41% in 2024.
- A 5-year view of Receivables - Other shows it stood at $61.9 million in 2021, then crashed by 58.74% to $25.5 million in 2022, then skyrocketed by 282.87% to $97.8 million in 2023, then fell by 5.72% to $92.2 million in 2024, then crashed by 73.31% to $24.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Other were $24.6 million in Q3 2025, $52.6 million in Q2 2025, and $39.7 million in Q1 2025.